Published in J Clin Invest on February 01, 1994
Dasatinib sensitizes KRAS mutant colorectal tumors to cetuximab. Oncogene (2010) 1.88
Carcinogenesis in IBD: potential targets for the prevention of colorectal cancer. Nat Rev Gastroenterol Hepatol (2009) 1.80
The role of Src in solid tumors. Oncologist (2009) 1.72
SRC-mediated phosphorylation of focal adhesion kinase couples actin and adhesion dynamics to survival signaling. Mol Cell Biol (2004) 1.70
Identification of the SRC pyrimidine-binding protein (SPy) as hnRNP K: implications in the regulation of SRC1A transcription. Nucleic Acids Res (2003) 1.26
Dok-1 independently attenuates Ras/mitogen-activated protein kinase and Src/c-myc pathways to inhibit platelet-derived growth factor-induced mitogenesis. Mol Cell Biol (2006) 1.05
Downregulation of Rap1GAP in human tumor cells alters cell/matrix and cell/cell adhesion. Mol Cell Biol (2010) 1.03
Src activity increases and Yes activity decreases during mitosis of human colon carcinoma cells. Mol Cell Biol (1995) 1.03
Potential molecular mechanism for c-Src kinase-mediated regulation of intestinal cell migration. J Biol Chem (2008) 1.01
Elevated c-Src is linked to altered cell-matrix adhesion rather than proliferation in KM12C human colorectal cancer cells. Br J Cancer (2002) 1.01
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. Int J Colorectal Dis (2011) 0.95
Src family kinases mediate betel quid-induced oral cancer cell motility and could be a biomarker for early invasion in oral squamous cell carcinoma. Neoplasia (2008) 0.91
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypes. Mol Cancer Res (2012) 0.88
Antiproliferative effect of sulindac in colonic neoplasia prevention: role of COOH-terminal Src kinase. Mol Cancer Ther (2008) 0.87
Progression of familial adenomatous polyposis (FAP) colonic cells after transfer of the src or polyoma middle T oncogenes: cooperation between src and HGF/Met in invasion. Br J Cancer (1997) 0.86
EGFR(s) in aging and carcinogenesis of the gastrointestinal tract. Curr Protein Pept Sci (2010) 0.81
Genetic variability in EGFR, Src and HER2 and risk of colorectal adenoma and cancer. Int J Mol Epidemiol Genet (2011) 0.81
Src activity alters alpha3 integrin expression in colon tumor cells. Clin Exp Metastasis (2008) 0.81
The tyrosine phosphatase PTPRO sensitizes colon cancer cells to anti-EGFR therapy through activation of SRC-mediated EGFR signaling. Oncotarget (2014) 0.80
Phosphorylated c-Src is a novel predictor for recurrence in cervical squamous cell cancer patients. Int J Clin Exp Pathol (2013) 0.76
Src-signaling interference impairs the dissemination of blood-borne tumor cells. Cell Tissue Res (2012) 0.75
Plasminogen activator inhibitor-1 is increased in colonic epithelial cells from patients with colitis-associated cancer. J Crohns Colitis (2012) 0.75
A genetic model for colorectal tumorigenesis. Cell (1990) 44.37
Genetic alterations during colorectal-tumor development. N Engl J Med (1988) 26.82
Oncogenes and signal transduction. Cell (1991) 14.84
Clues to the pathogenesis of familial colorectal cancer. Science (1993) 14.52
Identification and characterization of the familial adenomatous polyposis coli gene. Cell (1991) 14.46
Mutations in the p53 gene occur in diverse human tumour types. Nature (1989) 13.62
Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature (1993) 12.74
Chromosome 17 deletions and p53 gene mutations in colorectal carcinomas. Science (1989) 11.53
Identification of FAP locus genes from chromosome 5q21. Science (1991) 11.41
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients. Science (1991) 9.89
APC mutations occur early during colorectal tumorigenesis. Nature (1992) 9.50
Identification of a chromosome 18q gene that is altered in colorectal cancers. Science (1990) 8.32
Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol (1983) 8.24
Isolation of monoclonal antibodies that recognize the transforming proteins of avian sarcoma viruses. J Virol (1983) 7.22
Ulcerative colitis and colorectal cancer. A population-based study. N Engl J Med (1990) 6.87
The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg (1954) 6.74
Molecular themes in oncogenesis. Cell (1991) 6.73
Identification of deletion mutations and three new genes at the familial polyposis locus. Cell (1991) 5.42
Association between the PDGF receptor and members of the src family of tyrosine kinases. Cell (1990) 4.83
Cell transformation by pp60c-src mutated in the carboxy-terminal regulatory domain. Cell (1987) 4.63
Phosphorylation sites in enolase and lactate dehydrogenase utilized by tyrosine protein kinases in vivo and in vitro. J Biol Chem (1984) 4.20
Genetic mapping of a locus predisposing to human colorectal cancer. Science (1993) 4.12
Cooperation between oncogenes. Cell (1991) 3.88
A tail of two src's: mutatis mutandis. Cell (1987) 3.28
The when and how of Src regulation. Cell (1993) 3.07
Neoplastic progression in ulcerative colitis: histology, DNA content, and loss of a p53 allele. Gastroenterology (1992) 2.35
Altered sites of tyrosine phosphorylation in pp60c-src associated with polyomavirus middle tumor antigen. Mol Cell Biol (1986) 2.32
pp60c-src activation in human colon carcinoma. J Clin Invest (1989) 2.07
Activation of pp60c-src protein kinase activity in human colon carcinoma. Proc Natl Acad Sci U S A (1987) 1.92
Activation of the pp60c-src protein kinase is an early event in colonic carcinogenesis. Proc Natl Acad Sci U S A (1990) 1.76
Analysis of pp60c-src protein kinase activity in human tumor cell lines and tissues. J Biol Chem (1986) 1.67
c-Ki-ras gene mutations in dysplasia and carcinomas complicating ulcerative colitis. Br J Cancer (1991) 1.61
Structural and functional modification of pp60c-src associated with polyoma middle tumor antigen from infected or transformed cells. Mol Cell Biol (1985) 1.60
c-Ki-ras mutations in chronic ulcerative colitis and sporadic colon carcinoma. Gastroenterology (1990) 1.59
p53 point mutations in dysplastic and cancerous ulcerative colitis lesions. Gastroenterology (1993) 1.36
Alterations in pp60c-src accompany differentiation of neurons from rat embryo striatum. Mol Cell Biol (1987) 1.35
c-Yes tyrosine kinase activity in human colon carcinoma. Oncogene (1993) 1.35
Analysis of pp60c-src in human colon carcinoma and normal human colon mucosal cells. Oncogene Res (1987) 1.29
Signal transduction by the SRC family of tyrosine protein kinases in hemopoietic cells. Cell Growth Differ (1991) 1.24
Activation of c-Ki-ras in human gastrointestinal dysplasias determined by direct sequencing of polymerase chain reaction products. Cancer Res (1990) 1.20
Expression of c-myc in non-malignant and pre-malignant gastrointestinal disorders. J Pathol (1987) 1.09
Expression of the myc gene family in different stages of human colorectal cancer. Oncogene (1989) 1.08
pp60c-src expression in the developing rat brain. Proc Natl Acad Sci U S A (1988) 1.07
Expression and interactions of the Src family of tyrosine protein kinases in T lymphocytes. Adv Cancer Res (1991) 1.02
c-Ki-ras mutations in dysplastic fields and cancers in ulcerative colitis. Gastroenterology (1992) 0.99
Effect of herbimycin A on growth and pp60c-src activity in human colon tumor cell lines. Oncogene (1991) 0.90
Alterations in the expression of pp60c-src and p56lck associated with butyrate-induced differentiation of human colon carcinoma cells. Oncogene Res (1989) 0.88
Distribution of cells expressing myc proteins in human colorectal epithelium, polyps, and malignant tumors. Cancer Res (1992) 0.88
Intestinal crypt cells contain higher levels of cytoskeletal-associated pp60c-src protein tyrosine kinase activity than do differentiated enterocytes. Oncogene (1993) 0.87
Preneoplastic lesions induced by myc and src oncogenes in a heterotopic rat colon. Oncogene (1991) 0.81
Epithelioid haemangioma-like vascular proliferation in AIDS: manifestation of cat scratch disease bacillus infection? Lancet (1988) 1.92
Cutaneous vascular lesions and disseminated cat-scratch disease in patients with the acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. Ann Intern Med (1988) 1.56
Bacillary angiomatosis. The histopathology and differential diagnosis of a pseudoneoplastic infection in patients with human immunodeficiency virus disease. Am J Surg Pathol (1989) 1.19
Desmoplastic and spindle-cell malignant melanoma. An immunohistochemical study. Am J Surg Pathol (1996) 1.08
Systemic embolization from a mitral valve papillary endocardial fibroma detected by two-dimensional echocardiography. Am Heart J (1981) 1.06
Radiation injury of the normal and neoplastic prostate. Am J Surg Pathol (1982) 1.05
Benign lymphangioendothelioma. J Am Acad Dermatol (1994) 0.93
Differential diagnosis of Kaposi's sarcoma. Arch Pathol Lab Med (1985) 0.92
Reduced hyaluronan in keloid tissue and cultured keloid fibroblasts. J Invest Dermatol (2000) 0.90
Undifferentiated sarcoma arising in an augmented ileocystoplasty patch. J Urol (1980) 0.89
Intestinal crypt cells contain higher levels of cytoskeletal-associated pp60c-src protein tyrosine kinase activity than do differentiated enterocytes. Oncogene (1993) 0.87
Morphologic and clinical determinants of response to therapy in small cell carcinoma of the lung. Cancer (1983) 0.86
Pigmented spindle cell nevus. Clinical and histologic review of 90 cases. Am J Surg Pathol (1984) 0.84
Identification of herpes simplex virus DNA in lesions of erythema multiforme by the polymerase chain reaction. J Am Acad Dermatol (1991) 0.83
Lymphomatoid papulosis associated with plaque-stage and granulomatous mycosis fungoides. Arch Dermatol (1985) 0.82
Kaposi's sarcoma in young homosexual men: a histopathologic study with particular reference to lymph node involvement. Arch Pathol Lab Med (1982) 0.81
Effects of moisturization on epidermal homeostasis and differentiation. Clin Exp Dermatol (2006) 0.79
Histologic analysis of the thermal effect on epidermal and dermal structures following treatment with the superpulsed CO2 laser and the erbium: YAG laser: an in vivo study. Lasers Surg Med (1999) 0.79
Cutaneous cytomegalovirus vasculitis: an unusual clinical presentation of a common opportunistic pathogen. Hum Pathol (1982) 0.79
In vivo model of histologic changes after treatment with the superpulsed CO(2) laser, erbium:YAG laser, and blended lasers: a 4- to 6-month prospective histologic and clinical study. Lasers Surg Med (2000) 0.79
Desmoplastic neurotropic malignant melanoma. Pathology (Phila) (1994) 0.78
Ewing's sarcoma of the spinal epidural space: report of two cases. J Neurol Neurosurg Psychiatry (1978) 0.78
Infiltrative basal cell carcinoma occurring in sites of biopsy-proven nodular basal cell carcinoma. J Cutan Pathol (1998) 0.77
Optic nerve head involvement with cytomegalovirus in an adult with lymphoma. Arch Ophthalmol (1978) 0.77
Pathology: dysplastic nevi. West J Med (1986) 0.75
Superior vena caval syndrome. Arch Dermatol (1978) 0.75
The validity of ex vivo laser skin treatment for histological analysis. A prospective controlled study. Arch Facial Plast Surg (2000) 0.75
Steatocystoma multiplex. Report of a florid case and a review. Arch Dermatol (1979) 0.75
Increased proportion of aggressive-growth basal cell carcinoma in the Veterans Affairs population of Palo Alto, California. J Am Acad Dermatol (1996) 0.75
Basal cell carcinoma with tumor epithelial and stromal giant cells: a variant of pleomorphic basal cell carcinoma. Am J Dermatopathol (1999) 0.75
A nodule on the side of the neck in a child. Branchial cleft cyst. Arch Dermatol (1992) 0.75
Kartagener syndrome: report of a case with mesangiocapillary glomerulonephritis. Arch Pathol Lab Med (1977) 0.75
Dysplastic nevi can be diagnosed and graded reproducibly: a longitudinal study. J Am Acad Dermatol (1992) 0.75